Loading...

PVC Overcapacity And Debt Burden Will Persist Yet Long-Term Margins Should Gradually Improve

Published
13 Dec 25
n/a
n/a
AnalystLowTarget's Fair Value
n/a
Loading
1Y
-47.3%
7D
1.3%

Author's Valuation

₹31015.3% undervalued intrinsic discount

AnalystLowTarget Fair Value

Catalysts

About Chemplast Sanmar

Chemplast Sanmar is an integrated specialty chemicals and PVC player with operations spanning paste and suspension PVC, custom manufactured chemicals, value added chlorochemicals and emerging refrigerant gases.

What are the underlying business or industry changes driving this perspective?

  • Although the new Paste PVC plant at Cuddalore is running above full utilization and domestic demand from automotive and footwear is recovering, persistent low priced imports from Europe risk keeping realizations depressed, which could limit EBITDA margin normalization and delay a return to net profitability.
  • Although global PVC capacity rationalization and potential policy action in China could gradually tighten supply, any prolonged weakness in Chinese construction activity and continued dumping into India could keep Suspension PVC spreads structurally lower, capping revenue growth and compressing gross margins.
  • While the Custom Manufactured Chemicals division is steadily commercializing new molecules with long term contracts and a visible capacity pipeline, slower than expected ramp up of newly launched agrochemical molecules due to global price pressure may push out the timeline to reach INR 1,000 crores plus revenue and 20 to 25 percent EBITDA margins.
  • Although CMCD and refrigerant gas capacities are being added at the existing sites to benefit from operating leverage, the balance sheet is already carrying INR 1,319 crores of net debt and any further delay in cash flow breakeven could keep interest costs elevated and suppress earnings per share for several years.
  • While green power initiatives and conscious make or buy decisions in caustic soda can structurally lower power and input costs, recurring operational issues and weak chloromethane and caustic pricing in an oversupplied Indian market may offset much of these benefits, limiting improvement in net margins and free cash flow generation.
NSEI:CHEMPLASTS Earnings & Revenue Growth as at Dec 2025
NSEI:CHEMPLASTS Earnings & Revenue Growth as at Dec 2025

Assumptions

This narrative explores a more pessimistic perspective on Chemplast Sanmar compared to the consensus, based on a Fair Value that aligns with the bearish cohort of analysts. How have these above catalysts been quantified?

  • The bearish analysts are assuming Chemplast Sanmar's revenue will grow by 13.0% annually over the next 3 years.
  • The bearish analysts assume that profit margins will increase from -5.0% today to 5.1% in 3 years time.
  • The bearish analysts expect earnings to reach ₹3.2 billion (and earnings per share of ₹21.25) by about December 2028, up from ₹-2.2 billion today. However, there is some disagreement amongst the analysts with the more bullish ones expecting earnings as high as ₹7.7 billion.
  • In order for the above numbers to justify the price target of the more bearish analyst cohort, the company would need to trade at a PE ratio of 22.9x on those 2028 earnings, up from -18.9x today. This future PE is lower than the current PE for the IN Chemicals industry at 23.4x.
  • The bearish analysts expect the number of shares outstanding to decline by 0.34% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 14.64%, as per the Simply Wall St company report.
NSEI:CHEMPLASTS Future EPS Growth as at Dec 2025
NSEI:CHEMPLASTS Future EPS Growth as at Dec 2025

Risks

What could happen that would invalidate this narrative?

  • Global PVC overcapacity and weak construction demand in China could keep Suspension and Paste PVC spreads structurally compressed for longer than expected. This would restrain pricing power and stall any meaningful improvement in revenue and EBITDA margins.
  • Delays, dilution or non implementation of trade protection measures such as antidumping duties and quality control norms on PVC imports may allow sustained dumping from China and Europe. This could undermine domestic realizations and prolong net losses and weak free cash flow.
  • Prolonged pricing pressure in global agrochemicals driven by Chinese overcapacity could slow the ramp up of newly commercialized custom manufactured molecules. As a result, the CMCD division could fall short of targeted INR 1,000 crores plus revenue and 20 to 25 percent EBITDA margins, thereby delaying earnings growth.
  • High consolidated net debt of INR 1,319 crores combined with years of subdued EBIT generation raises the risk that cash flows from new capacities, refrigerant gases and green power initiatives prove insufficient. This could force tighter capital allocation or potential equity dilution and limit improvement in net margins and earnings.

Valuation

How have all the factors above been brought together to estimate a fair value?

  • The assumed bearish price target for Chemplast Sanmar is ₹310.0, which represents up to two standard deviations below the consensus price target of ₹433.5. This valuation is based on what can be assumed as the expectations of Chemplast Sanmar's future earnings growth, profit margins and other risk factors from analysts on the more bearish end of the spectrum.
  • However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of ₹504.0, and the most bearish reporting a price target of just ₹310.0.
  • In order for you to agree with the more bearish analyst cohort, you'd need to believe that by 2028, revenues will be ₹62.6 billion, earnings will come to ₹3.2 billion, and it would be trading on a PE ratio of 22.9x, assuming you use a discount rate of 14.6%.
  • Given the current share price of ₹261.4, the analyst price target of ₹310.0 is 15.7% higher.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Chemplast Sanmar?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystLowTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystLowTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystLowTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives